Soleno Therapeutics (SLNO) News Today $37.01 +2.95 (+8.66%) (As of 12/7/2023 ET) Add Compare Share Share Today's Range$33.89▼$38.1150-Day Range$21.93▼$37.0152-Week Range$0.85▼$38.20Volume518,072 shsAverage Volume394,151 shsMarket Capitalization$1.13 billionP/E RatioN/ADividend YieldN/APrice Target$38.00 HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSoleno Therapeutics, Inc. (NASDAQ:SLNO) CFO James H. Mackaness Sells 4,186 Shares of Stockamericanbankingnews.com - December 5 at 5:24 AMSoleno Therapeutics, Inc. (NASDAQ:SLNO) CEO Bhatnagar Anish Sells 27,716 Shares of Stockamericanbankingnews.com - December 5 at 4:28 AMSoleno Therapeutics, Inc. (NASDAQ:SLNO) CEO Sells $696,387.36 in Stockamericanbankingnews.com - December 3 at 4:37 AMSoleno Therapeutics (NASDAQ:SLNO) Sets New 52-Week High at $30.42americanbankingnews.com - December 3 at 3:19 AMInsider Sell Alert: CFO James Mackaness Sells 8,081 Shares of Soleno Therapeutics Inc (SLNO)finance.yahoo.com - December 1 at 9:03 AM3 Biotech Stocks With Big-Time Breakthrough Potentialfinance.yahoo.com - November 28 at 2:19 AMSoleno Therapeutics: Impressive Data, But Never Forget Amarinseekingalpha.com - November 26 at 12:37 PM4 Analysts Have This to Say About Soleno Therapeuticsmarkets.businessinsider.com - November 21 at 3:34 PMUndervalued Potential: Soleno Therapeutics’ Promising Prospects and Upward Price Target Revisionmarkets.businessinsider.com - November 10 at 7:10 PMSoleno Therapeutics Inc SLNOmorningstar.com - November 7 at 9:59 AMSoleno Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 7 at 9:59 AMSoleno Therapeutics (SLNO) Price Target Increased by 14.43% to 37.74msn.com - November 3 at 10:14 AMThe Ten Most-Shorted Stocks Include Huge Market Movers In 2023finance.yahoo.com - October 16 at 10:54 AMXerox, Mastercraft Boat, and More Stocks See Action From Activist Investorsfinance.yahoo.com - October 6 at 11:22 PMSoleno Therapeutics (SLNO) Price Target Increased by 162.16% to 32.98msn.com - October 5 at 10:21 AMSoleno Therapeutics Announces DCCR Data Presentation at the Foundation for Prader-Willi Research Symposiumfinance.yahoo.com - October 4 at 6:19 PMCorrecting & Replacing -- Soleno Therapeutics Announces DCCR Data Presentation at the Foundation for Prader-Willi Research Symposiumfinance.yahoo.com - October 4 at 6:19 PMMeet Soleno Therapeutics, The Company Whose Hunger Suppressant Sent Shares Flying 505%msn.com - October 3 at 10:22 AMSoleno Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Concurrent Private Placement of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Sharesfinance.yahoo.com - October 2 at 6:46 PMSoleno Therapeutics' 10% owner buys $15M worth of stockmsn.com - September 29 at 4:06 PMSoleno Therapeutics, Inc. (NASDAQ:SLNO) Major Shareholder Perceptive Advisors Llc Buys 250,000 Sharesmarketbeat.com - September 29 at 3:20 PMSoleno Therapeutics Announces Proposed Public Offering of Common Stock and/or Pre-Funded Warrants and a Concurrent Private Placement of Common Stock and/or Pre-Funded Warrantsfinance.yahoo.com - September 27 at 8:10 PMWhy Shares of Soleno Therapeutics Dropped on Wednesdayfinance.yahoo.com - September 27 at 8:10 PMSoleno Therapeutics Stock Dives After Its Meteoric Rise on Positive Study Resultsfinance.yahoo.com - September 27 at 3:09 PMIndividual investors in Soleno Therapeutics, Inc. (NASDAQ:SLNO) are its biggest bettors, and their bets paid off as stock gained 494% last weekfinance.yahoo.com - September 27 at 10:08 AMSoleno (SLNO) Soars as Prader-Willi Syndrome Study Meets Goalfinance.yahoo.com - September 27 at 10:08 AMSoleno Therapeutics Shares Take Flight After Strong Study Datamarketwatch.com - September 26 at 6:24 PMSoleno Therapeutics' Study Outcome Bolsters Confidence In PWS Treatmentmarkets.businessinsider.com - September 26 at 6:24 PMSoleno Catapults 505% After Its Pill Controls Hunger In Obesity-Causing Genetic Diseasefinance.yahoo.com - September 26 at 6:24 PMSoleno Says Study C602 Met Primary Endpoint; Stock Surges In Premarketmarkets.businessinsider.com - September 26 at 1:24 PMGenetic Disorder Focused Soleno Therapeutics' Stock Is Trading 4X Today - Here's Why?msn.com - September 26 at 1:24 PMSoleno Catapults Almost 400% After Its Pill Controls Hunger In Obesity-Causing Genetic Diseasefinance.yahoo.com - September 26 at 1:24 PMWhy Shares of Soleno Therapeutics Are Booming on Tuesdayfinance.yahoo.com - September 26 at 1:24 PMWhy Is Soleno Therapeutics (SLNO) Stock Up 420% Today?investorplace.com - September 26 at 1:06 PMmarketbeat.com - September 26 at 10:20 AMmarketbeat.com - September 26 at 10:10 AMmarketbeat.com - September 26 at 9:57 AMmarketbeat.com - September 26 at 9:48 AMmarketbeat.com - September 26 at 9:37 AMSoleno Therapeutics Shares Soar Premarket on Prader-Willi Study Successmarketwatch.com - September 26 at 8:24 AMSoleno Therapeutics Announces Positive Statistically Significant Top-line Results from Randomized Withdrawal Period of Study C602 of DCCR for Prader-Willi Syndromefinance.yahoo.com - September 26 at 8:24 AMSoleno Therapeutics to Present at the Cantor Global Healthcare Conferencefinance.yahoo.com - September 25 at 9:41 AMOppenheimer Maintains Soleno Therapeutics (SLNO) Outperform Recommendationmsn.com - September 15 at 2:10 PMOppenheimer Maintains Outperform Rating for Soleno Therapeutics: Here's What You Need To Knowmarkets.businessinsider.com - September 15 at 2:10 PMCantor Fitzgerald Reiterates Soleno Therapeutics (SLNO) Overweight Recommendationnasdaq.com - September 1 at 9:22 AMSoleno Therapeutics Announces Appointment of Industry Veteran Matthew Pauls, J.D., M.B.A. to Board of Directorsfinance.yahoo.com - August 16 at 9:12 AMSoleno Therapeutics (SLNO) Price Target Increased by 37.04% to 12.58msn.com - August 2 at 7:07 AMKeep The Hunger On: Analyst Says Soleno Therapeutics' Upside Potential Much Higher Than Downside Riskmarkets.businessinsider.com - July 11 at 5:20 PMLL Flooring and Ingevity Stock See Action From Activist Investorsfinance.yahoo.com - June 2 at 10:06 PMMassive Insider Trade At Soleno Therapeuticsbenzinga.com - June 2 at 12:04 PM Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address SLNO Media Mentions By Week SLNO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLNO News Sentiment▼-0.730.51▲Average Medical News Sentiment SLNO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLNO Articles This Week▼101▲SLNO Articles Average Week Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BioLife Solutions News Zynex News AxoGen News Semler Scientific News Outset Medical News InMode News TransMedics Group News LivaNova News Integer News CONMED News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:SLNO) was last updated on 12/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soleno Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.